Top-Paying Oncology Specialties Worldwide in 2025
SIOG and OncoDaily Announce Strategic Partnership to Advance Global Geriatric Oncology
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025
Razelle Kurzrock: Our Commentary and Implications for Future Precision Studies
Anirban Maitra: Encorafenib, Cetuximab, and Nivolumab in Microsatellite Stable BRAFV600E mCRC
Minhua Chu: Rui Therapeutics Completed a Series A Financing Exceeding RMB 200 Million
Applications are Open for IDEA Program with Special QI Mentorship Opportunity - ASCO
Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma
